Changing Vaccine Policies Provides Opportunities For Drugmakers

BMI View: The Japanese government's appointment of Sanofi Pasteur to begin the clinical development of a monovalent inactivated polio vaccine in Japan reinforces the government's commitment to increasing the population's access to vaccines. However, we believe the government still has a long way to go if it is to implement vaccines policies that align with those of the developed world - ActHIB was launched in 2008, Cervarix was approved in 2009 and Prevenar was launched in 2010.

To read the full article, please choose one of the following options: